US Bancorp’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20,000
Closed -$29.2K 4179
2025
Q1
$29.2K Buy
+20,000
New +$39K ﹤0.01% 3002
2020
Q3
Sell
-800
Closed -$12K 3721
2020
Q2
$12K Buy
800
+400
+100% +$5.4K ﹤0.01% 3028
2020
Q1
$3K Buy
+400
New +$3.14K ﹤0.01% 3359

Other funds holding CGEN

US Bancorp's CGEN Position: Q2 2025 in Review

US Bancorp sold out of Compugen (CGEN) in Q2 2025, closing a stake of 20,000 shares — an estimated $29.2K sold.

US Bancorp first reported a position in CGEN in Q1 2020 and held it in 3 quarters. The position peaked at $29.2K in Q1 2025. 70 funds tracked by Wall St. Rank hold CGEN as of Q2 2025.

  • US Bancorp reported no remaining Compugen position as of Q2 2025 after selling out during the quarter.
  • US Bancorp sold 20,000 Compugen shares in Q2 2025, an estimated $29.2K.
  • US Bancorp first reported a position in Compugen in Q1 2020 and held it in 3 quarters.
  • US Bancorp's Compugen position peaked at $29.2K in Q1 2025.
  • 70 funds tracked by Wall St. Rank held Compugen as of Q2 2025.

Based on US Bancorp's 13F filing for Q2 2025, filed 24 Jul 2025.